Fog Pharma

Cequent Pharmaceuticals, a privately held biopharmaceutical company based in Cambridge, Massachusetts, is at the forefront of developing novel therapeutics aimed at preventing and treating a variety of human diseases, including inflammatory diseases and cancer. Established in 2006, the company leverages its proprietary TransKingdom RNA interference (tkRNAi) technology to target specific disease-causing genes safely and effectively using non-pathogenic bacteria as delivery vehicles. The tkRNAi platform enables the development of drug candidates that can silence one or more cellular genes simultaneously, offering a powerful alternative to traditional small molecules and monoclonal antibodies. With its foundation rooted in groundbreaking scientific research from the Institut Pasteur in Paris and Beth Israel Deaconess Medical Center at Harvard Medical School, Cequent is poised to make significant advancements in the biopharmaceutical landscape. Generated from the website

Rhythm Pharmaceuticals is a biopharmaceutical company based in Boston, MA, focused on developing and commercializing peptide therapeutics for the treatment of rare genetic disorders. The company's research and development efforts are centered around addressing unmet medical needs in the field of metabolic disorders. With a commitment to advancing innovative treatments, Rhythm Pharmaceuticals leverages its expertise in peptide biology to create potential therapies for patients with rare diseases. Through strategic partnerships and a dedicated team of professionals, the company aims to make a meaningful impact in improving the lives of individuals affected by these conditions. Generated from their business information

P P Manufacturing Inc is a company located in Framingham, MA, specializing in manufacturing solutions. They appear to have encountered an error, specifically an "Action Aborted Error 5804," which may indicate a technical issue related to their operations. The incident also references an IP address, 34.209.92.239, suggesting that their systems or services may be monitored or accessed online. This highlights their engagement with digital technologies within their manufacturing processes. Generated from the website